IL18 and mature T-cell and NK-cell non-Hodgkin lymphoma: IL-18 upregulates TLR4 expression in PTCL cells, activating the downstream NF-κB-mediated anti-apoptotic pathway to promote tumor proliferation and chemoresistance.